Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Infectious keratitis after Boston type 1 keratoprosthesis implantation.
[aniridia]
To
determine
the
incidence
,
clinical
features
,
and
outcomes
of
infectious
keratitis
after
Boston
type
1
keratoprosthesis
(
Kpro
)
implantation
.
Ten
cases
of
infectious
keratitis
were
identified
in
a
retrospective
chart
review
of
105
patients
(
126
eyes
)
who
received
Kpro
between
November
2004
and
November
2010
at
the
Cincinnati
Eye
Institute
and
were
followed
for
at
least
1
month
(
range
,
1
-
66
months
;
mean
,
25
months
)
.
The
incidence
was
7
.
9
%
.
Patient
diagnoses
included
4
chemical
injuries
,
3
Stevens-
Johnson
syndrome
,
2
ocular
cicatricial
pemphigoid
,
and
1
congenital
aniridia
.
Kpro
implantation
was
indicated
in
2
eyes
for
a
failed
ocular
surface
and
in
8
for
penetrating
keratoplasty
failure
.
Four
patients
were
contact
lens
intolerant
or
noncompliant
.
All
were
on
topical
vancomycin
and
moxifloxacin
for
prophylaxis
and
2
were
on
topical
amphotericin
for
prophylaxis
.
Three
infiltrates
were
culture
negative
,
5
were
fungal
(
3
Candida
,
1
Fusarium
,
1
Dactylaria
constricta
)
,
and
2
were
bacterial
(
Rhodococcus
equi
and
Gram
-negative
cocci
)
.
All
patients
were
managed
with
topical
agents
and
4
were
given
an
oral
antifungal
agent
.
Four
patients
had
Kpro
removal
with
therapeutic
penetrating
keratoplasty
and
1
had
Kpro
replacement
.
At
final
follow-up
,
only
2
patients
retained
their
preinfection
best
vision
.
Risk
factors
for
infectious
keratitis
included
a
diagnosis
of
cicatrizing
conjunctivitis
(
Stevens-
Johnson
syndrome
,
ocular
cicatricial
pemphigoid
,
or
chemical
injury
)
and
a
history
of
persistent
epithelial
defect
(
P
=
0
.
0003
and
0
.
0142
,
respectively
)
.
Contact
lens
wear
,
vancomycin
use
,
and
a
history
of
systemic
immunosuppression
(
or
use
at
the
time
of
infection
)
were
not
statistically
significant
risk
factors
.
Infectious
keratitis
after
Kpro
can
occur
even
when
patients
are
on
vancomycin
and
a
fourth
-generation
fluoroquinolone
for
prophylaxis
.
Fungal
organisms
are
a
growing
cause
for
concern
,
and
we
present
the
details
of
the
first
reported
case
of
ocular
D
.
constricta
.
The
evolution
of
our
management
and
prophylaxis
strategy
for
fungal
keratitis
after
Kpro
implantation
is
also
described
.
Diseases
Validation
Diseases presenting
"conjunctivitis"
symptom
acute rheumatic fever
aniridia
kindler syndrome
lamellar ichthyosis
pyomyositis
triple a syndrome
This symptom has already been validated